Incidence of cardiometabolic outcomes among people living with HIV‐1 initiated on integrase strand transfer inhibitor versus non‐integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United States

INTRODUCTION: Integrase strand transfer inhibitor (INSTI)‐containing antiretroviral therapy (ART) has been associated with weight gain, though there is limited information on associations between ART‐related weight gain and cardiometabolic outcomes among people living with HIV‐1 (PLWH). We, therefor...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebeiro, Peter F., Emond, Bruno, Rossi, Carmine, Bookhart, Brahim K., Shah, Aditi, Caron‐Lapointe, Gabrielle, Lafeuille, Marie‐Hélène, Donga, Prina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258864/
https://www.ncbi.nlm.nih.gov/pubmed/37306118
http://dx.doi.org/10.1002/jia2.26123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258864/
https://www.ncbi.nlm.nih.gov/pubmed/37306118
http://dx.doi.org/10.1002/jia2.26123

Ejemplares similares